Endoangel Withdrawal Overspeed Analysis

NCT05069571 | Unknown

• 1 other identifier: EA-21-009
• Study Type: observational
• Target: 1,210
• Locations: 1 country
• Sites: 1

Brief Summary

Exploring the relationship between the percentage of overspeed of colonoscopy withdrawal and the rate of adenoma detection.

Conditions

Colorectal Neoplasms

Outcome Measures

Primary Outcomes (1)

• Adenoma detection rate

  3 months

Secondary Outcomes (1)

• Proportion of withdrawal overspeed

  3 months

Interventions

Endoangel OTHER

Collecting the colonoscopy videos and analyzing the correlation between withdrawal overspeed proportion and adenoma detection rate.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients need to receive the colonoscopy examination.

You may qualify if:

• Males or females who are over 18 years old (inclusive);
• Enteroscopy and related examinations are needed to further clarify the characteristics of digestive tract diseases;
• Able to read, understand and sign the informed consent form;
• The researcher believes that the subject can understand the process of the clinical research, is willing and able to complete all the research procedures and follow-up visits, and cooperate with the research procedures.

You may not qualify if:

• Participated in other clinical trials, signed an informed consent form and within the follow-up period of other clinical trials;
• Abuse of drugs or alcohol or mental disorders in the last 5 years;
• Women during pregnancy or breastfeeding;
• Subjects with previous history of bowel surgery;
• The investigator believes that the subject is not suitable for enteroscopy and related examinations;
• The investigator believes that the subject is not suitable for high-risk diseases or other special circumstances to participate in clinical trials.
• Patients with gastrointestinal bleeding;
• Known or highly suspected allergy to any ingredient of bowel cleansing agent;
• Restricted activities or any mental or physical condition impairs their ability to drink intestinal cleansing preparations;
• Known or suspected intestinal obstruction or perforation, toxic megacolon, most colectomy, heart failure (grade III or IV), severe cardiovascular disease, severe liver failure or end, renal insufficiency, etc.

Sponsors & Collaborators

• Renmin Hospital of Wuhan University: lead

Study Sites (1)

Renmin Hospital of Wuhan University

Wuhan, Hubei, 430060, China

RECRUITING

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Rectal Diseases

Central Study Contacts

Honggang Yu, Doctor

CONTACT

13871281899; yuhonggang@whu.edu.cn

Liwen Yao, Doctor

CONTACT

15827416837; 292779656@qq.com

Study Design

• Study Type: observational
• Observational Model: CASE CROSSOVER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 24, 2021
• First Posted: October 6, 2021
• Study Start: March 1, 2020
• Primary Completion: November 1, 2021
• Study Completion: February 1, 2022
• Last Updated: October 6, 2021

Record last verified: 2021-09

Locations

CN (1)